Stay updated on Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.

Latest updates to the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedMajor update: new operating-status notice and a v3.2.0 version release, replacing the prior v3.1.0.SummaryDifference9%

- Check33 days agoChange DetectedVersion update: from v3.0.2 to v3.1.0.SummaryDifference0.2%

- Check47 days agoChange DetectedVersion bumped from v3.0.1 to v3.0.2; the Back to Top element was removed.SummaryDifference0.6%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.6%

- Check61 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location details, while removing specific state, country, and city information. This suggests a shift towards a more generalized presentation of location data.SummaryDifference47%

- Check76 days agoChange DetectedThe web page has been updated from version v2.16.11 to v2.16.12.SummaryDifference0.3%

Stay in the know with updates to Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Insulin Efsitora vs Degludec in Type 2 Diabetes Clinical Trial page.